Considering the variability in the prevalence of obesity and metabolic syndrome (MetS) in adult CAH patients, our aim was to evaluate whether NR3C1 polymorphisms could account for the development of this adverse metabolic profile in a series of CAH patients from same center. The gene discussed is NR3C1; the disease is congenital adrenal hyperplasia.